Department of Oral Biology, College of Dentistry, University of Illinois Chicago, Chicago, Illinois 60612, United States ...

Ivor Elrifi, CEO of Tiziana Life Sciences, commented, “Partnering with Renaissance is a significant milestone in our mission to bring intranasal foralumab to patients in need. Their proven track ...

Ivor Elrifi, CEO of Tiziana Life Sciences, commented, “Partnering with Renaissance is a significant milestone in our mission ...

Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal ...

If you’ve ever wondered how Thon’s year-round fundraising efforts manage to raise that money, and where the money goes ...

文章预测 外泌体将成为2025年护肤领域的热门趋势之一。

A study led by scientists from the Max Planck Institute for Plant Breeding Research in Cologne has shown that the ability to ...

To date, 14 patients have now been enrolled in the expanded access program. The first 10 patients have all shown either an improvement or stability of disease within 6 months ...